Crohn's disease Trials in Kashiwa Shi, Japan
Conditions / Crohn's disease / Kashiwa Shi, Japan
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05068284 | A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE2 |
| NCT06226883 | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease | RECRUITING | — |
| NCT03105128 | A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE3 |
| NCT03105102 | A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04173273 | A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | RECRUITING | PHASE3 |
| NCT06332534 | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease | RECRUITING | — |
| NCT05995353 | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE3 |
| NCT06063967 | A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. | ACTIVE_NOT_RECRUITING | PHASE3 |